Bolno Paul's Form 4 filing
Wave Life Sciences, Inc. (WVE) · filed Mar 7, 2025
- Accession no.
- 0000950170-25-035835
- Filed
- Mar 7, 2025
- Trade date
- Mar 7, 2025
- Filing delay
- Same day
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.62M. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bolno PaulCIK 0001657710 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 7, 2025 | Ordinary Shares | MOption exerciseAcquired | +169,025 | $2.48 | +$419,182 | 507,376 | Direct | |
| Mar 7, 2025 | Ordinary Shares | SSaleDisposed | −169,025 | $9.57 | −$1,617,569.25 | 338,351 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 7, 2025 | Ordinary Shares | MOption exerciseDisposed | −120,966 | $0.00 | $0 | 0 | Direct | |
| Mar 7, 2025 | Ordinary Shares | MOption exerciseDisposed | −48,059 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.